What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Daniel Catovsky spends much of his time researching Immunology, Chronic lymphocytic leukemia, Internal medicine, Leukemia and Pathology.
His Immunology research is multidisciplinary, incorporating perspectives in Cancer, Clinical trial, Allele and Single-nucleotide polymorphism.
Daniel Catovsky interconnects Aneuploidy, Antigen, Lymphocyte, Bone marrow and Fludarabine in the investigation of issues within Chronic lymphocytic leukemia.
Daniel Catovsky has included themes like Gastroenterology, Surgery and Oncology in his Internal medicine study.
His work is dedicated to discovering how Leukemia, Pentostatin are connected with Cladribine and other disciplines.
The concepts of his Pathology study are interwoven with issues in Immunophenotyping, Hairy Cell Leukemia Variant and B cell.
His most cited work include:
- Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia: A Report of the French-American-British Cooperative Group (2584 citations)
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines (2519 citations)
- Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. (665 citations)
What are the main themes of his work throughout his whole career to date?
Daniel Catovsky focuses on Immunology, Internal medicine, Chronic lymphocytic leukemia, Leukemia and Pathology.
His Immunology study integrates concerns from other disciplines, such as Disease and Stem cell marker.
His Internal medicine research includes themes of Gastroenterology, Surgery and Oncology.
His studies deal with areas such as Cancer, Cancer research and Single-nucleotide polymorphism, Genotype as well as Chronic lymphocytic leukemia.
His Hairy cell leukemia and Prolymphocytic leukemia study are his primary interests in Leukemia.
Pathology is closely attributed to Immunophenotyping in his study.
He most often published in these fields:
- Immunology (32.96%)
- Internal medicine (32.77%)
- Chronic lymphocytic leukemia (28.09%)
What were the highlights of his more recent work (between 2008-2021)?
- Internal medicine (32.77%)
- Chronic lymphocytic leukemia (28.09%)
- Immunology (32.96%)
In recent papers he was focusing on the following fields of study:
Daniel Catovsky mainly focuses on Internal medicine, Chronic lymphocytic leukemia, Immunology, Oncology and Leukemia.
Daniel Catovsky combines subjects such as Gastroenterology and Surgery with his study of Internal medicine.
His research in Chronic lymphocytic leukemia intersects with topics in Cancer, Genome-wide association study, Genetic predisposition, Genetic variation and Fludarabine.
His specific area of interest is Immunology, where Daniel Catovsky studies Hairy cell leukemia.
His study focuses on the intersection of Oncology and fields such as Proportional hazards model with connections in the field of Stage and Multivariate analysis.
His Leukemia research includes elements of Mutation and Pathology.
Between 2008 and 2021, his most popular works were:
- iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL (392 citations)
- Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial (205 citations)
- Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk (196 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His primary scientific interests are in Internal medicine, Chronic lymphocytic leukemia, Leukemia, Immunology and Oncology.
His biological study deals with issues like Gastroenterology, which deal with fields such as Surgery, Pentostatin and Rituximab.
His biological study spans a wide range of topics, including Genome-wide association study, Genetic predisposition, Cyclophosphamide, Fludarabine and Allele.
In his work, Immunophenotyping and Molecular genetics is strongly intertwined with Pathology, which is a subfield of Leukemia.
His Immunology research is multidisciplinary, incorporating elements of Clinical trial, Genotype and Risk factor.
His work deals with themes such as Disease progression, Hairy Cell Leukemia Variant, Mutation and Immunoglobulin heavy chain, which intersect with Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
